Christopher Kratochvil, M.D. |
UNMC Chancellor Harold M. Maurer, M.D., announced Dr. Kratochvil’s new roles, which took effect Feb. 1.
“Chris will lead the expansion of contract-related clinical research on campus,” Dr. Maurer said. “He will have the authority to commit both UNMC and The Nebraska Medical Center to research protocols in our areas of expertise.
“This should lead to greater research opportunities for our faculty and benefits to our patients and students.”
|
UNeHealth also will provide a focus and impetus for the growth of industry-funded clinical research at UNMC, said Tom Rosenquist, Ph.D., vice chancellor for research.
“Dr. Kratochvil has a long history of successful work in clinical research and in regulatory affairs related to clinic research that makes him uniquely suited for medical director of this new enterprise,” Dr. Rosenquist said. “He has expressed great enthusiasm for this unique new position, and, under his leadership, I look forward to significant growth in our industry-sponsored trials.”
Through this new position, Dr. Kratochvil will unify and restructure the clinical research resources throughout campus to help streamline the clinical trial process for investigators.
|
“We have an outstanding opportunity to build upon our current clinical research at UNMC and NMC, while partnering with external clinical research organizations and pharmaceutical companies,” he said.